SCOTT D SANDELL Insider Trading Transactions
Get free email notifications about insider trading for SCOTT D SANDELL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SCOTT D SANDELL. SCOTT D SANDELL is 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Marker Therapeutics, Inc. ($MRKR) and 10% Owner in ZTI MERGER SUBSIDIARY III INC ($ZHNE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and in MYOGEN INC ($MYOG) and 10% Owner in MYOGEN INC ($MYOG) and in PHARMION CORP ($PHRM) and 10% Owner in PHARMION CORP ($PHRM) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in Vitae Pharmaceuticals, Inc ($VTAE) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in Liquidia Technologies Inc ($LQDA) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in INTERCELL USA, INC. ($IOMI) and 10% Owner in INNERWORKINGS INC ($INWK) and 10% Owner in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in MULESOFT, INC ($MULE) and Director in Data Domain, Inc. ($DDUP) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Cloudflare, Inc. ($NET) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Sprout Social, Inc. ($SPT) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Elastic N.V. ($ESTC) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Surface Oncology, Inc. ($SURF) and Director in Bloom Energy Corp ($BE) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX).
Latest Insider Trading Transactions of SCOTT D SANDELL
Sentiment: All, AKAO, ADAP, AKUS, APPN, ARDM, ABIO, ARDX, AVEO, BE, CRCM, CASC, CBIO, CERC, NET, DDUP, EAR, ESTC, EPZM, GNCA, GLYC, HPTX, INHX, INWK, INZY, IOMI, ILIU, LIQDA, MRKR, MRSN, MTCR, MIRM, MULE, MYOG, NKTX, PRTK, PHRM, RARX, RGLS, RYTM, ROKA, SPT, SUPN, SURF, SYBX, TSRO, TCON, TRVI, VTAE, VG, ZHNE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 54.32 | 26,304 | 1,428,875 | 9,590,988 | 9.6 M to 9.6 M (+0.28 %) |
Feb 27 2018 | ABIO | ARCA biopharma, In ... | SANDELL SCOTT D | 10% Owner | Sell | S | 0.50 | 1,460,209 | 731,273 | 0 | 1.5 M to 0 (-100.00 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | SANDELL SCOTT D | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 15 2018 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 2,724,202 | 0 | 0 | |
Feb 15 2018 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 679 | 0 | 679 | 0 to 679 |
Feb 15 2018 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 4,946 | 0 | 13,895 | 8.9 K to 13.9 K (+55.27 %) |
Feb 15 2018 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 1,352 | 0 | 1,352 | 0 to 1.4 K |
Feb 15 2018 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 8,949 | 0 | 8,949 | 0 to 8.9 K |
Feb 15 2018 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 13,621 | 0 | 0 | 13.6 K to 0 (-100.00 %) |
Feb 15 2018 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 13,621 | 0 | 13,621 | 0 to 13.6 K |
Feb 15 2018 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 27,242 | 0 | 0 | 27.2 K to 0 (-100.00 %) |
Feb 15 2018 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 27,242 | 0 | 27,242 | 0 to 27.2 K |
Feb 15 2018 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 2,724,202 | 0 | 0 | 2.7 M to 0 (-100.00 %) |
Feb 15 2018 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 2,724,202 | 0 | 2,724,202 | 0 to 2.7 M |
Jan 26 2018 | MIRN | SYNLOGIC, INC. | SANDELL SCOTT D | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
Nov 27 2017 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 569,620 | 0 | 2,724,202 | |
Nov 27 2017 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Sell | S | 19.49 | 569,620 | 11,101,894 | 0 | 569.6 K to 0 (-100.00 %) |
Nov 27 2017 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 569,620 | 0 | 569,620 | 0 to 569.6 K |
Nov 21 2017 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 2,820,516 | 0 | 3,293,822 | |
Nov 21 2017 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Sell | S | 19.49 | 2,820,516 | 54,971,857 | 0 | 2.8 M to 0 (-100.00 %) |
Nov 21 2017 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 2,820,516 | 0 | 2,820,516 | 0 to 2.8 M |
Nov 08 2017 | CRCM | Care.com Inc | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 504 | 0 | 504 | 0 to 504 |
Nov 08 2017 | CRCM | Care.com Inc | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 2,302 | 0 | 2,302 | 0 to 2.3 K |
Nov 08 2017 | CRCM | Care.com Inc | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Nov 08 2017 | CRCM | Care.com Inc | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Nov 08 2017 | CRCM | Care.com Inc | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 2,256,013 | 3.3 M to 2.3 M (-30.71 %) |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 2,927,708 | 0 | 0 | |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 1,402,870 | 0 | 0 | |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | SANDELL SCOTT D | 10% Owner | Buy | P | 17.00 | 550,000 | 9,350,000 | 4,909,956 | 4.4 M to 4.9 M (+12.61 %) |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 2,927,708 | 0 | 4,359,956 | 1.4 M to 4.4 M (+204.41 %) |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 1,402,870 | 0 | 1,432,248 | 29.4 K to 1.4 M (+4,775.24 %) |
Aug 30 2017 | MIRN | SYNLOGIC, INC. | SANDELL SCOTT D | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 2,216,626 | 0 | 0 | |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 18,001,419 | 0 | 0 | |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 11,931,173 | 0 | 0 | |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Buy | P | 15.00 | 1,000,000 | 15,000,000 | 8,140,138 | 7.1 M to 8.1 M (+14.01 %) |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 7,140,138 | 0 | 7,140,138 | 0 to 7.1 M |
May 31 2017 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 6,114,338 | 0 | 6,114,338 | |
May 31 2017 | APPN | APPIAN CORP | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 6,114,338 | 0 | 0 | |
Mar 29 2017 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 0.50 | 6,000,000 | 3,000,000 | 16,362,694 | 10.4 M to 16.4 M (+57.90 %) |
Mar 28 2017 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 0.70 | 12,870,000 | 9,009,000 | 72,139,000 | 59.3 M to 72.1 M (+21.71 %) |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | J | 0.00 | 858,978 | 0 | 858,978 | |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | J | 0.00 | 2,576,939 | 0 | 2,576,939 | |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | J | 0.00 | 12,679,970 | 0 | 12,679,970 | |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 227,125 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 631,853 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 681,377 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 1,895,562 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 605,668 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 2,064,048 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 8,000,038 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 1,689,436 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 858,978 | 0 | 0 | 859 K to 0 (-100.00 %) |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 858,978 | 0 | 858,978 | 0 to 859 K |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 2,576,939 | 0 | 0 | 2.6 M to 0 (-100.00 %) |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 2,576,939 | 0 | 2,576,939 | 0 to 2.6 M |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 12,679,970 | 0 | 0 | 12.7 M to 0 (-100.00 %) |
Mar 22 2017 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 12,359,190 | 0 | 12,679,970 | 320.8 K to 12.7 M (+3,852.86 %) |
Dec 19 2016 | AKAO | Achaogen Inc | SANDELL SCOTT D | 10% Owner | Buy | P | 13.50 | 500,000 | 6,750,000 | 5,215,128 | 4.7 M to 5.2 M (+10.60 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | SANDELL SCOTT D | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 4,362,472 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 4,689,657 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 12,447,605 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | SANDELL SCOTT D | 10% Owner | Option Exercise | X | 0.07 | 80,658 | 5,646 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | SANDELL SCOTT D | 10% Owner | Buy | P | 13.00 | 338,462 | 4,400,006 | 3,490,073 | 3.2 M to 3.5 M (+10.74 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 623,210 | 0 | 3,151,611 | 2.5 M to 3.2 M (+24.65 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 669,951 | 0 | 2,528,401 | 1.9 M to 2.5 M (+36.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 1,778,227 | 0 | 1,858,450 | 80.2 K to 1.9 M (+2,216.60 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | SANDELL SCOTT D | 10% Owner | Sell | S | 13.00 | 435 | 5,655 | 80,223 | 80.7 K to 80.2 K (-0.54 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | SANDELL SCOTT D | 10% Owner | Buy | X | 0.07 | 80,658 | 5,646 | 80,658 | 0 to 80.7 K |
Sep 23 2016 | ROKA | Roka BioScience, I ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | SANDELL SCOTT D | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Jul 20 2016 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 8.73 | 763,650 | 6,666,665 | 2,665,519 | 1.9 M to 2.7 M (+40.15 %) |
Jul 20 2016 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 8.73 | 763,651 | 6,666,673 | 2,665,520 | 1.9 M to 2.7 M (+40.15 %) |
Jul 20 2016 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 8.73 | 763,650 | 6,666,665 | 8,752,543 | 8 M to 8.8 M (+9.56 %) |
Jul 20 2016 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 8.73 | 763,650 | 6,666,665 | 2,665,519 | 1.9 M to 2.7 M (+40.15 %) |
Jul 20 2016 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 8.73 | 763,651 | 6,666,673 | 2,665,520 | 1.9 M to 2.7 M (+40.15 %) |
Jul 20 2016 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 8.73 | 763,650 | 6,666,665 | 8,752,543 | 8 M to 8.8 M (+9.56 %) |
Mar 18 2016 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 35.19 | 710,429 | 24,999,997 | 710,429 | 0 to 710.4 K |
Mar 18 2016 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 35.19 | 710,429 | 24,999,997 | 9,564,684 | 8.9 M to 9.6 M (+8.02 %) |
Jan 14 2016 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 10.00 | 500,000 | 5,000,000 | 1,901,869 | 1.4 M to 1.9 M (+35.67 %) |
Jan 14 2016 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 10.00 | 500,000 | 5,000,000 | 1,901,869 | 1.4 M to 1.9 M (+35.67 %) |
Jan 14 2016 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 10.00 | 500,000 | 5,000,000 | 7,988,893 | 7.5 M to 8 M (+6.68 %) |
Jan 12 2016 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
Nov 18 2015 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Option Exercise | X | 0.33 | 9,445 | 3,117 | 0 | |
Nov 18 2015 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Sell | S | 6.91 | 452 | 3,123 | 4,490,751 | 4.5 M to 4.5 M (-0.01 %) |
Nov 18 2015 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Buy | X | 0.33 | 9,445 | 3,117 | 4,491,203 | 4.5 M to 4.5 M (+0.21 %) |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 212,650 | 0 | 212,650 | 0 to 212.7 K |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 82,811 | 0 | 82,811 | 0 to 82.8 K |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 1,172,932 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 1,172,932 | 0 | 1,172,932 | 0 to 1.2 M |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 3,820,625 | 0 | 3,820,625 | 7.6 M to 3.8 M (-50.00 %) |
Oct 20 2015 | CERC | Cerecor Inc. | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 16,638,880 | 0 | 0 | |
Oct 20 2015 | CERC | Cerecor Inc. | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 594,245 | 0 | 594,245 | 0 to 594.2 K |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 583,559 | 0 | 0 | |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 1,241,650 | 0 | 0 | |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | SANDELL SCOTT D | 10% Owner | Buy | P | 7.00 | 857,142 | 5,999,994 | 2,971,517 | 2.1 M to 3 M (+40.54 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 31,650 | 0 | 2,114,375 | 2.1 M to 2.1 M (+1.52 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 583,559 | 0 | 2,082,725 | 1.5 M to 2.1 M (+38.93 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 257,516 | 0 | 1,499,166 | 1.2 M to 1.5 M (+20.74 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 1,241,650 | 0 | 1,241,650 | 0 to 1.2 M |
Jul 02 2015 | VTAE | Vitae Pharmaceutic ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 556 | 0 | 556 | 0 to 556 |
Jul 02 2015 | VTAE | Vitae Pharmaceutic ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 1,134 | 0 | 1,134 | 0 to 1.1 K |
Jul 02 2015 | VTAE | Vitae Pharmaceutic ... | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 8,250 | 0 | 0 | 8.3 K to 0 (-100.00 %) |
Jul 02 2015 | VTAE | Vitae Pharmaceutic ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 8,250 | 0 | 8,250 | 0 to 8.3 K |
Jul 02 2015 | VTAE | Vitae Pharmaceutic ... | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 825,000 | 0 | 1,786,564 | 2.6 M to 1.8 M (-31.59 %) |
Jun 19 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Sell | S | 16.02 | 48,796 | 781,800 | 0 | 48.8 K to 0 (-100.00 %) |
Jun 19 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Sell | S | 16.67 | 63,085 | 1,051,804 | 48,796 | 111.9 K to 48.8 K (-56.39 %) |
Jun 19 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Sell | S | 17.03 | 24,716 | 420,817 | 0 | 24.7 K to 0 (-100.00 %) |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Sell | S | 16.85 | 55,105 | 928,668 | 111,881 | 167 K to 111.9 K (-33.00 %) |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Sell | S | 17.01 | 40,332 | 685,902 | 24,716 | 65 K to 24.7 K (-62.00 %) |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 166,986 | 0 | 166,986 | 0 to 167 K |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 65,048 | 0 | 65,048 | 0 to 65 K |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 921,000 | 0 | 0 | 921 K to 0 (-100.00 %) |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 921,000 | 0 | 921,000 | 0 to 921 K |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 3,000,000 | 0 | 7,641,250 | 10.6 M to 7.6 M (-28.19 %) |
Jun 09 2015 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 13.91 | 420,561 | 5,850,004 | 420,561 | |
Jun 09 2015 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 13.91 | 420,561 | 5,850,004 | 420,561 | |
Jun 09 2015 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 13.91 | 560,748 | 7,800,005 | 560,748 | |
Jun 09 2015 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 10.70 | 1,401,869 | 14,999,998 | 1,401,869 | 0 to 1.4 M |
Jun 09 2015 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 10.70 | 1,401,869 | 14,999,998 | 1,401,869 | 0 to 1.4 M |
Jun 09 2015 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 10.70 | 1,869,159 | 20,000,001 | 7,488,893 | 5.6 M to 7.5 M (+33.26 %) |
Jun 04 2015 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Sell | S | 58.13 | 629 | 36,564 | 0 | 629 to 0 (-100.00 %) |
Jun 04 2015 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Sell | S | 57.55 | 1,500 | 86,332 | 629 | 2.1 K to 629 (-70.46 %) |
Jun 04 2015 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Sell | S | 59.72 | 504 | 30,099 | 0 | 504 to 0 (-100.00 %) |
Jun 02 2015 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 2,129 | 0 | 2,129 | 0 to 2.1 K |
Jun 02 2015 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 504 | 0 | 504 | 0 to 504 |
Jun 02 2015 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Jun 02 2015 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jun 02 2015 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 8,854,255 | 9.9 M to 8.9 M (-10.15 %) |
May 11 2015 | HPTX | HYPERION THERAPEUT ... | SANDELL SCOTT D | 10% Owner | Sell | U | 46.00 | 2,384,221 | 109,674,166 | 0 | 2.4 M to 0 (-100.00 %) |
Oct 30 2009 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 1.46 | 791,015 | 1,154,882 | 791,015 | |
Oct 30 2009 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 1.46 | 263,671 | 384,960 | 263,671 | |
Oct 30 2009 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 1.28 | 1,757,812 | 2,249,999 | 6,898,294 | 5.1 M to 6.9 M (+34.20 %) |
Oct 30 2009 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 1.28 | 585,937 | 749,999 | 1,941,407 | 1.4 M to 1.9 M (+43.23 %) |
Jul 27 2009 | DDUP | Data Domain, Inc. | SANDELL SCOTT D | Director | Sell | U | 33.50 | 43,750 | 1,465,625 | 0 | 43.8 K to 0 (-100.00 %) |
Jul 21 2009 | DDUP | Data Domain, Inc. | SANDELL SCOTT D | Director | Option Exercise | M | 8.90 | 43,750 | 389,375 | 0 | |
Jul 21 2009 | DDUP | Data Domain, Inc. | SANDELL SCOTT D | Director | Buy | M | 8.90 | 43,750 | 389,375 | 43,750 | 0 to 43.8 K |
Jul 21 2009 | DDUP | Data Domain, Inc. | SANDELL SCOTT D | Director | Sell | U | 33.50 | 71,250 | 2,386,875 | 0 | 71.3 K to 0 (-100.00 %) |
Jul 21 2009 | DDUP | Data Domain, Inc. | SANDELL SCOTT D | Director | Sell | U | 33.50 | 109,393 | 3,664,666 | 0 | 109.4 K to 0 (-100.00 %) |
Jul 21 2009 | DDUP | Data Domain, Inc. | SANDELL SCOTT D | Director | Sell | U | 33.50 | 895,523 | 30,000,021 | 0 | 895.5 K to 0 (-100.00 %) |
Jul 15 2009 | DDUP | Data Domain, Inc. | SANDELL SCOTT D | Director | Option Exercise | M | 24.44 | 15,000 | 366,600 | 0 | |
Jul 15 2009 | DDUP | Data Domain, Inc. | SANDELL SCOTT D | Director | Option Exercise | M | 8.90 | 56,250 | 500,625 | 43,750 | |
Jul 15 2009 | DDUP | Data Domain, Inc. | SANDELL SCOTT D | Director | Buy | M | 24.44 | 15,000 | 366,600 | 71,250 | 56.3 K to 71.3 K (+26.67 %) |
Jul 15 2009 | DDUP | Data Domain, Inc. | SANDELL SCOTT D | Director | Buy | M | 8.90 | 56,250 | 500,625 | 56,250 | 0 to 56.3 K |
Jul 10 2009 | DDUP | Data Domain, Inc. | SANDELL SCOTT D | Director | Sell | J | 0.00 | 7,741,629 | 0 | 895,523 | 8.6 M to 895.5 K (-89.63 %) |
Jul 02 2009 | DDUP | Data Domain, Inc. | SANDELL SCOTT D | Director | Option Exercise | A | 33.21 | 15,000 | 498,150 | 15,000 |